Other Species / Isoforms
  FKBP5 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S13-p
GAKNNEEsPtATVAE
Upstream
0 17
Treatment
  • nocodazole
FKBP5 (human) GAKNNEEsPtATVAE S13-p
FKBP5 (mouse) GTSNNGENPAATMTE N13
FKBP5 (rat) GTSNNEENPAATVVE N13
T15-p
KNNEEsPtATVAEQG
0 2
FKBP5 (human) KNNEEsPtATVAEQG T15-p
FKBP5 (mouse) SNNGENPAATMTEQG A15
FKBP5 (rat) SNNEENPAATVVEQG A15
K28-ac
QGEDITSkKDRGVLK
Upstream
Downstream
1 1
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • apoptosis, induced
  • carcinogenesis, altered
Treatment
  • nicotinamide
  • siRNA
FKBP5 (human) QGEDITSkKDRGVLK K28-ac
FKBP5 (mouse) QGEDITTKKDRGVLK K28
FKBP5 (rat) QGEDITTKKDRGVLK K28
K28-ub
QGEDITSkKDRGVLK
0 1
FKBP5 (human) QGEDITSkKDRGVLK K28-ub
FKBP5 (mouse) QGEDITTKKDRGVLK K28
FKBP5 (rat) QGEDITTKKDRGVLK K28
Y54-p
PMIGDKVyVHYKGKL
Upstream
Downstream
1 14
Effects on Modified Protein
  • activity, inhibited
  • molecular association, regulation
  • protein degradation
  • ubiquitination
Effects on Biological Processes:
  • autophagy, inhibited
  • carcinogenesis, induced
  • signaling pathway regulation
Putative in vivo kinases:
  • SRMS (human)
FKBP5 (human) PMIGDKVyVHYKGKL Y54-p
FKBP5 (mouse) PMFGDKVyVHYKGML Y54-p
FKBP5 (rat) PMIGDKVYVHYKGKL Y54
K66-ac
GKLSNGKkFDSSHDR
0 1
FKBP5 (human) GKLSNGKkFDSSHDR K66-ac
FKBP5 (mouse) GMLSDGKKFDSSHDR K66
FKBP5 (rat) GKLSNGKKFDSSRDR K66
E75
DSSHDRNEPFVFSLG
0 1
FKBP5 (human) DSSHDRNEPFVFSLG E75
FKBP5 (mouse) DSSHDRKkPFAFSLG K75-ub
FKBP5 (rat) DSSRDRNEPFVFSLG E75
K83
PFVFSLGKGQVIKAW
0 1
FKBP5 (human) PFVFSLGKGQVIKAW K83
FKBP5 (mouse) PFAFSLGQGQVIKAW Q83
FKBP5 (rat) PFVFSLGkGQVIKAW K83-ac
S115
KPEYAYGSAGSLPKI
0 1
FKBP5 (human) KPEYAYGSAGSLPKI S115
FKBP5 (mouse) KPEYAYGsAGHLQKI S115-p
FKBP5 (rat) KPEYAYGSAGSLPKI S115
K155-ac
IIRRTKRkGEGYSNP
Upstream
Downstream
1 1
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • apoptosis, induced
  • carcinogenesis, altered
Treatment
  • nicotinamide
  • siRNA
FKBP5 (human) IIRRTKRkGEGYSNP K155-ac
FKBP5 (mouse) VIRRIKRKGEGYSNP K155
FKBP5 (rat) IIRRIKRKGEGYSNP K155
K155
IIRRTKRKGEGYSNP
0 1
FKBP5 (human) IIRRTKRKGEGYSNP K155
FKBP5 (mouse) VIRRIKRkGEGYSNP K155-ub
FKBP5 (rat) IIRRIKRKGEGYSNP K155
K208-ub
GIDKALEkMQREEQC
0 1
FKBP5 (human) GIDKALEkMQREEQC K208-ub
FKBP5 (mouse) GIDKALVKMQREEQC K208
FKBP5 (rat) GIDKALEKMQREEQC K208
Y243-p
EPNAELIyEVTLkSF
0 6
FKBP5 (human) EPNAELIyEVTLkSF Y243-p
FKBP5 (mouse) DPNAELMYEVTLKSF Y243
FKBP5 (rat) EPNAELMYEVTLKSF Y243
K248-ac
LIyEVTLkSFEKAKE
1 1
FKBP5 (human) LIyEVTLkSFEKAKE K248-ac
FKBP5 (mouse) LMYEVTLKSFEKAKE K248
FKBP5 (rat) LMYEVTLKSFEKAKE K248
K248-ub
LIyEVTLkSFEKAKE
0 1
FKBP5 (human) LIyEVTLkSFEKAKE K248-ub
FKBP5 (mouse) LMYEVTLKSFEKAKE K248
FKBP5 (rat) LMYEVTLKSFEKAKE K248
K274-ub
QAAIVKEkGTVYFKG
0 1
FKBP5 (human) QAAIVKEkGTVYFKG K274-ub
FKBP5 (mouse) QAAIVKEKGTVYFKG K274
FKBP5 (rat) QAAIVKEKGTVYFKG K274
K342-ub
KAVECCDkALGLDSA
0 2
FKBP5 (human) KAVECCDkALGLDSA K342-ub
FKBP5 (mouse) KAVECCDKALGLDSA K342
FKBP5 (rat) KAVECCDKALGLDSA K342
K352-ub
GLDSANEkGLYRrGE
0 7
FKBP5 (human) GLDSANEkGLYRrGE K352-ub
FKBP5 (mouse) GLDSANEkGLYRRGE K352-ub
FKBP5 (rat) GLDSANEKGLYRRGE K352
R357-m1
NEkGLYRrGEAQLLM
0 1
FKBP5 (human) NEkGLYRrGEAQLLM R357-m1
FKBP5 (mouse) NEkGLYRRGEAQLLM R357
FKBP5 (rat) NEKGLYRRGEAQLLM R357
K376-ub
SAKGDFEkVLEVNPQ
0 2
FKBP5 (human) SAKGDFEkVLEVNPQ K376-ub
FKBP5 (mouse) SAKGDFEKVLAVNPQ K376
FKBP5 (rat) SAKGDFEKVLEVNPQ K376
K385-ub
LEVNPQNkAARLQIS
0 4
FKBP5 (human) LEVNPQNkAARLQIS K385-ub
FKBP5 (mouse) LAVNPQNRAARLQIS R385
FKBP5 (rat) LEVNPQNKAARLQIS K385
Y409-p
NERDRRIyANMFkkF
0 18
FKBP5 (human) NERDRRIyANMFkkF Y409-p
FKBP5 (mouse) NERDRRVYANMFKKF Y409
FKBP5 (rat) NERDRRVYANMFKKF Y409
K414-ac
RIyANMFkkFAEQDA
1 12
FKBP5 (human) RIyANMFkkFAEQDA K414-ac
FKBP5 (mouse) RVYANMFKKFAERDA K414
FKBP5 (rat) RVYANMFKKFAEQDA K414
K415-ac
IyANMFkkFAEQDAk
1 2
FKBP5 (human) IyANMFkkFAEQDAk K415-ac
FKBP5 (mouse) VYANMFKKFAERDAK K415
FKBP5 (rat) VYANMFKKFAEQDAK K415
K422-ub
kFAEQDAkEEANKAM
0 1
FKBP5 (human) kFAEQDAkEEANKAM K422-ub
FKBP5 (mouse) KFAERDAKEEASKAG K422
FKBP5 (rat) KFAEQDAKEEASKAL K422
K422-sm
kFAEQDAkEEANKAM
Upstream
Downstream
1 1
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
Effects on Biological Processes:
  • signaling pathway regulation
  • transcription, inhibited
Regulatory protein:
  • SENP2 (human)
Treatment
  • siRNA
FKBP5 (human) kFAEQDAkEEANKAM K422-sm
FKBP5 (mouse) KFAERDAKEEASKAG K422
FKBP5 (rat) KFAEQDAKEEASKAL K422
T433-p
NKAMGKKtsEGVTNE
0 1
FKBP5 (human) NKAMGKKtsEGVTNE T433-p
FKBP5 (mouse) SKAGSKKAVEGAAGK A433
FKBP5 (rat) SKALSKKAVEGAAGK A433
S434-p
KAMGKKtsEGVTNEk
0 1
FKBP5 (human) KAMGKKtsEGVTNEk S434-p
FKBP5 (mouse) KAGSKKAVEGAAGKQ V434
FKBP5 (rat) KALSKKAVEGAAGKK V434
K441-ac
sEGVTNEkGtDsQAM
1 2
FKBP5 (human) sEGVTNEkGtDsQAM K441-ac
FKBP5 (mouse) AVEGAAGKQHEsQAM K440
FKBP5 (rat) VEGAAGKKHESQTMG K441
K441-ub
sEGVTNEkGtDsQAM
0 1
FKBP5 (human) sEGVTNEkGtDsQAM K441-ub
FKBP5 (mouse) AVEGAAGKQHEsQAM K440
FKBP5 (rat) VEGAAGKKHESQTMG K441
T443-p
GVTNEkGtDsQAMEE
0 5
FKBP5 (human) GVTNEkGtDsQAMEE T443-p
FKBP5 (mouse) EGAAGKQHEsQAMEE H442
FKBP5 (rat) EGAAGKKHESQTMGE H442
S445-p
TNEkGtDsQAMEEEK
Upstream
0 30
Treatment
  • ionizing_radiation
  • ischemia
  • nocodazole
FKBP5 (human) TNEkGtDsQAMEEEK S445-p
FKBP5 (mouse) AAGKQHEsQAMEEGK S444-p
FKBP5 (rat) AAGKKHESQTMGEGK S444